VANDENBULKE assisted one of the biggest provider of finance administration services, acting as agent and security trustee in the context of a massive debt re-structuring of a clinical-stage biotechnology Group, for a global amount of more than US Dollar 1,000,000,000.-.
The multi-jurisdictional restructuring involved complex negotiations with lenders groups and capital market considerations, taking into account Notes that were listed on the Luxembourg Stock Exchange. It also entailed cross jurisdictional applications of insolvency law and litigation aspects. The restructuring was implemented through the enforcement of a Luxembourg law governed share pledge and the sale of the company to a holding company.
Our Luxembourg Banking & Finance team combined with the corporate-restructuring team provided successful assistance to them throughout the whole re-structuring and was the law firm in charge of leading the enforcement of the Luxembourg law governed share pledge and the sale of the biotechnology group.
// Finance //